Presbyopia is a progressive visual condition that has been found to significantly reduce quality of life.

To assess the impact of presbyopia and the coping strategies used to manage the condition, the Presbyopia Impact and Coping Questionnaire (PICQ) was developed in accordance with the development standards described in the Food and Drug Administration’s Patient-Reported Outcomes guidance.

While there were some differences in the patient population between rounds of qualitative interviews, the Impact and Coping strategies experienced were similar across groups.

Although the psychometric evaluation of the PICQ Coping and Impact scores was based on a sample of modest size, the results were confirmed in a separate sample, thus increasing the confidence in the stability of the instrument’s measurement properties.

The totality of the evidence from the qualitative research and the psychometric evaluation of the PICQ establishes a content-valid, parsimonious, and comprehensive instrument that produces domain scores with robust measurement properties.